The Motor Insurance Repair Research Centre announced this week that it is to conduct independenttrials of tracking systems and other advanced security devices to see how effective they are.
In an unprecedented move that could signal dramatic changes in the drug industry, GlaxoSmithKline is promising to make detailed data from its clinical trials available to independent researchers so that scientists can draw their own conclusions about the safety and effectiveness of its new drugs.